Hologic, Del Global strike DR deal
Del Global has licensed the rights and trademarks to digital radiography systems originally developed, manufactured, and marketed by Hologic. The agreement between the two companies paves the way for Del Global to begin manufacturing the
Del Global has licensed the rights and trademarks to digital radiography systems originally developed, manufactured, and marketed by Hologic. The agreement between the two companies paves the way for Del Global to begin manufacturing the direct-to-digital general radiography systems under the Epex, Epex ER, DR1000, Omniflex, and Radex brand names. Hologic will support the transfer of manufacturing from its Bedford, MA, facility to a Del facility in Chicago. Also in collaboration with Del, Hologic will provide ongoing service support to customers, as well as its DirectRay detector for integration into Del's finished products. The licensing agreement reflects a strategic shift by Hologic management away from manufacturing finished digital radiography equipment for sale to end users in favor of supplying digital detectors to OEMs.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
